All In Biotech

Drug Trial Radar · NCT07093580

Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants

Phase 1 Study of a Long-acting Injectable S-892216 in Healthy Adult Participants

Last checked: Nov 20, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 128 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

128

Planned (sponsor's estimate)

Start

Jul 29, 2025

Primary completion

Jun 30, 2028

Study completion Jun 30, 2028

Sponsor

Lead sponsor
ShionogiIndustry
Sponsor type
Industry
First posted
Jul 30, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics (PK) of single- and multiple-dose administration of S-892216-LAI in healthy adults.

Conditions

  • Healthy Participants

Interventions

  • S-892216-LAIDrug

    S-892216-LAI injection will be administered per schedule specified in the arm description.

  • PlaceboDrug

    Physiological saline will be administered per schedule specified in the arm description.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part: Number of Participants With Treatment-emergent Adverse Events (TEAEs)Time frame: Day 1 through Day 364
  2. Part 2: Number of Participants With TEAEsTime frame: Day 1 through Day 448

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Altasciences

    Cypress, California · Recruiting

  • ICON Clinical Research: Lenexa

    Lenexa, Kansas · Active not recruiting

  • ICON Clinical Research: Salt Lake City

    Salt Lake City, Utah · Active not recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.